Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Net Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Net Margin for 16 consecutive years, with 48.47% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin fell 6774.0% to 48.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.59%, a 1023.0% decrease, with the full-year FY2025 number at 3.43%, down 1639.0% from a year prior.
  • Net Margin was 48.47% for Q4 2025 at Lemaitre Vascular, down from 37.48% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 37.48% in Q3 2025 to a low of 59.1% in Q4 2023.
  • A 5-year average of 11.87% and a median of 17.72% in 2021 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: plummeted -7814bps in 2023, then skyrocketed 7837bps in 2024.
  • Lemaitre Vascular's Net Margin stood at 15.29% in 2021, then increased by 25bps to 19.04% in 2022, then tumbled by -410bps to 59.1% in 2023, then surged by 133bps to 19.26% in 2024, then crashed by -352bps to 48.47% in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Net Margin are 48.47% (Q4 2025), 37.48% (Q3 2025), and 28.13% (Q2 2025).